". . . to diabetes what Blackberry is to corporate America: easy connections, anytime, anywhere." — Dallas CEO Magazine

See Kevin's Presentation Given at the American Diabetes Association's
67th Scientific Sessions, Chicago

"Beyond Websites - Remote Diagnostics, Rules Engines and Social Networks for Developing Smart Patients" (slides with audio)

The Difference is Real Time

Timely, accurate information including patient blood glucose levels is critical for self care and team managment. Self-test data for people with diabetes is simply not available to the extended team including medical professionals, parents and family members, school nurses, researchers, training partners, etc... And, when the team needs reliable information, it is rarely available. Only with accurate and timely access to the patient record can informed medical recommendations be made to improve the patient's health.

Diabetech has developed a real-time intervention platform incorporating:

  • remote diagnostic wireless medical devices
  • wireless data communications
  • managed electronic patient health profiles
  • rules engine for intelligent patient education and management
  • social networks including Alerts, Reminders, Requests for Data, Reports and SMS/MMS/Mobile Messaging
  • web based administration, patient management, data review and collaboration

Diabetech's Role in Diabetes Technology

Diabetech designs, develops and tests next generation connected medical devices. These devices are fundamental to our diabetes intervention programs.

More about Diabetech's role in a recent Medical Product Outsourcing article "Driving Innovation in Diabetes Care"

New Diabetes Treatment and Monitoring Technology Means Opportunity for Both Patients and Medical Device Companies

McMahon, who founded the company after his daughter was diagnosed with Type 1 diabetes, has discovered that the medical community places most of the responsibility for care with patients and often doesn’t take into account the need for other support. “That is the number one thing: You don’t manage it by yourself,” McMahon said. He added that traditionally, the driving force behind new technology has been reimbursement—either government or private—rather than patient needs. With the firsthand perspective of a family affected by diabetes, McMahon developed the GlucoMON as a means of promoting compliance.  Full article . . .

Contact Diabetech

©2002-2008 Diabetech, LP, All Rights Reserved